COMPOSITIONS AND METHODS FOR TREATING T CELL EXHAUSTION

Expression systems comprising nucleic acids encoding HIV-1 protease cleavage site polypeptides

COMPOSITIONS AND METHODS FOR TREATING T CELL EXHAUSTION

Multivalent HIV vaccine boost compositions and methods of use

Poxvirus vectors encoding HIV antigens, and methods of use thereof

HIV vaccines comprising one or more population episensus antigens

HIV vaccines comprising one or more population episensus antigens

Antiviral vaccines with improved cellular immunogenicity

Methods of inducing an immune response against HIV-1 utilizing nucleic acids encoding polypeptides containing HIV-1 protease cleavage sites

JNK Inhibitor Molecules For Treatment Of Various Diseases

Poxvirus vectors encoding HIV antigens, and methods of use thereof

Antiviral vaccines with improved cellular immunogenicity

Recombinant HIV epitopes and uses thereof

Optimized HIV envelope gene and expression thereof

Cross-reactive T-cell epitopes of HIV, SIV, and FIV for vaccines in humans and cats

HIV vaccines comprising one or more population episensus antigens

Prophylactic protection against viral infections, particularly HIV

HIV and immunogenic peptide sequences and compositions

Optimized HIV envelope gene and expression thereof

Antiviral vaccines with improved cellular immunogenicity

Method and compositions

Attenuated recombinant vesicular stomatitis viruses comprising modified matrix proteins

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

JNK inhibitor molecules for treatment of various diseases

Methods and compositions for inhibiting diseases of the central nervous system

Adjuvant compositions and methods of use

Replication-competent adenoviral vectors

Human Immunodeficiency Virus type 1 group M consensus and mosaic envelope glycoproteins

Antiviral vaccines with improved cellular immunogenicity

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

Strain-independent amplification of pathogens and vaccines thereto

HIV peptides and immunogenic compositions

Chimeric non-integrating lentiviral genomes as vaccines against HIV-1

Attenuated recombinant vesicular stomatitis viruses comprising modified mutant matrix proteins

HIV consensus envelope sequences and methods for using the same

Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant

hTERT sequences and methods for using the same

Method of improving immune function in HIV-infected subjects on HAART by administering HIV-1 TAT

Peptide Sequences of HIV polypeptides and compositions thereof

HIV consensus envelope sequences and methods for using the same

Chimeric HIV fusion proteins as vaccines

Fusion proteins of HIV regulatory/accessory proteins

Fusion proteins of HIV regulatory/accessory proteins

GENERATION OF A BROAD T-CELL RESPONSE IN HUMANS AGAINST HIV

TAT Protein for preventing or treating AIDS

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) gag immunogens

Recombinant bacterium and methods of antigen and nucleic acid delivery

Antiviral vaccines with improved cellular immunogenicity

Immunogenic compositions for inducing an immune response to HIV

Nucleic acids encoding mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Covalently linked complexes of HIV TAT and ENV PROTEINS

Modified Tat Oyi protein with enhanced immunogenicity

Method for inducing a multiclade immune response against HIV utilizing a multigene and multiclade immunogen

Compositions and Methods for the Treatment and Prophylaxis of Multiple Strains and Subtypes of HIV-1

Dendritic cell vaccines

Tat DNA sequences, gene constructs, vaccine and processes thereof

LENTIVIRUS-BASED IMMUNOGENIC VECTORS

Methods of delivery of exogenous proteins to the cytosol and uses thereof

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

Broadly Representative Antigen Sequences and Method for Selection

Adjuvant compositions and methods of use

HPV vaccines and methods for using the same

Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef

Modified human immunodeficiency virus clade C envelope polypeptides obtained from a zambian isolate

Combined human papillomavirus VLP/gene delivery system and use thereof as a vaccine for prophylaxis and immunotherapy of infectious diseases and tumors

PEPTIDES SEQUENCES AND COMPOSITIONS

Fusion proteins of HIV regulatory/accessory proteins

Fusion proteins of HIV regulatory/accessory proteins

Methods and compositions for inhibiting diseases of the central nervous system

HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination

Fusion protein of HIV regulatory/accessory proteins

Vaccines against aids comprising cmv/r-nucleic acid constructs

CHIMERIC HIV FUSION PROTEINS AS VACCINES

HIV-GAG CODON-OPTIMISED DNA VACCINES

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens

Genetic constructs and compositions comprising RRE and CTE and uses thereof

Method for the reduction of viral loads in patients comprising the administration of -deficient human immunodeficiency virus (HIV)

METHOD OF ELICITING IMMUNE RESPONSE

Compositions and methods for the treatment and prophylaxis of multiple strains and subtypes of HIV-1

Immunological compositions

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

Strain-independent amplification of pathogens and vaccines thereto

Renta: an HIV immunogen and uses thereof

Covalently-linked complexes of HIV Tat and Env proteins

Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby

Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors

Adeno-associated virus AAV Rep78 major regulatory protein mutants thereof and uses thereof

Vaccine composition

VACCINE COMPRISING GP120 AND NEF AND/OR TAT FOR THE IMMUNIZATION AGAINST HIV

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

POLYNUCLEOTIDES ENCODING ANTIGENIC HIV TYPE B POLYPEPTIDES, POLYPEPTIDES, AND USES THEREOF

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

FUSION PROTEINS COMPRISING HIV-1 TAT AND/OR NEF PROTEINS

Adenoviral Vector Compositions

Use of Microparticles for Antigen Delivery

VIRAL GENE PRODUCTS AND METHODS FOR VACCINATION TO PREVENT VIRAL ASSOCIATED DISEASES

Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to hiv

Enhanced first generation adenovirus vaccines expressing condon optimized HIV1-Gag, Pol, Nef and modifications

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Compositions and methods for generating an immune response

Method

Hiv-gag codon-optimised dna vaccines

Immuno-adjuvant emulsion

Methods and compositions for impairing multiplication of HIV-1

Fusion proteins of non-attenuated HIV regulatory/accessory proteins

Ferritin fusion proteins for use in vaccines and other applications

Compositions and methods for delivery of genetic material

HIV TEV compositions and methods of use

Technology of intracellular delivery of DNA oligonucleotides to improve drug activity

Method of inducing an enhanced immune response against hiv

Use of inactive immunosuppressive and/or angiogenic immunogenic proteins, for producing secretory IgA's

Genetic constructs and compositions comprising RRE and CTE and uses thereof

Replication-competent adenoviral vectors

Vaccines against hiv-1 tat protein to generate neutralizing antibodies

DNA expression vectors and methods of use

Compositions comprising human immunodeficiency virus Tat adsorbed to the surface of anionic nanoparticles

Methods and compositions comprising bacteriophage nanoparticles

Fusion protein of hiv regulatory/accessory proteins

Methods of delivery of exogenous proteins to the cytosol and uses thereof

Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof

Preventive and therapeutic aids vaccines

Vaccine composition

Non-pathogenic strains of HIV-1

Methods of generating a humoral immune response against human immunodeficiency virus (HIV) comprising administering Nef apoptotic motif-containing polypeptide-conjugates

HIV pharmaccines

Hiv-1 virus tat-protein mutants

Method and kit for detection of tat protein with anti-tat oyi antibodies

Enhanced first generation adenovirus vaccines expressing codon optimized HIV1-Gag, Pol, Nef and modifications

Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv

Fusion proteins comprising HIV-1 Tat and/or Nef proteins

Novel chimeric rev, tat, and nef antigens